Contractor Positron opens radioactive-drug plant

Molecular imaging company Positron has opened a 10,000-square-foot cGMP-ready facility in Indiana for manufacturing both radioactive and non-radioactive pharma products and devices. The contract manufacturer, which specializes in nuclear cardiology, plans to focus initially on small batch, radioactive PET products. Positron release

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.